Caris Life Sciences, Inc. (CAI) vs Kymera Therapeutics, Inc. (KYMR)
A side-by-side comparison of Caris Life Sciences, Inc. and Kymera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAI
Caris Life Sciences, Inc.
$28.34HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
KYMR
Kymera Therapeutics, Inc.
$105.26HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — CAI vs KYMR
growth of $100 · dividends reinvested · last 1yCAI +8.5% (+8.5%/yr)KYMR +137.0% (+137.0%/yr)KYMR compounded faster over this window
CAI KYMR
CAI vs KYMR: by the numbers
- •KYMR is the larger company ($8.66B vs $8.01B market cap).
- •CAI is profitable (10.62% net margin) while KYMR runs a net loss (-285.41%).
- •CAI grew revenue faster over the past five years (26.15% vs 10.22% CAGR).
Metrics side by side
Valuation
| Metric | CAI | KYMR |
|---|---|---|
| P/E ratio | 79.18 | N/A |
| Forward P/E | 244.25 | N/A |
| P/S ratio | 8.10 | 82.47 |
| P/B ratio | 13.54 | 5.74 |
| EV / EBITDA | 44.66 | N/A |
| FCF yield | 1.83% | N/A |
Profitability
| Metric | CAI | KYMR |
|---|---|---|
| Gross margin | 69.66% | 101.98% |
| Operating margin | 5.56% | -891.33% |
| Net margin | 10.62% | -285.41% |
| ROE | 17.77% | -19.85% |
| ROIC | 14.76% | -22.30% |
Growth (annualized)
| Metric | CAI | KYMR |
|---|---|---|
| Revenue CAGR (5Y) | 26.15% | 10.22% |
| Total return CAGR (5Y) | N/A | 12.31% |
Frequently asked
- Which has grown faster, CAI or KYMR?
- Over the past five years, CAI grew revenue faster — CAI at a 26.15% CAGR versus KYMR at 10.22%.
- Is CAI or KYMR more profitable?
- CAI runs the higher net margin — CAI at 10.62% versus KYMR at -285.41%.
Go deeper
Dig into the metrics
Caris Life Sciences P/E ratioCaris Life Sciences ROEKymera Therapeutics ROECaris Life Sciences operating marginKymera Therapeutics operating marginCaris Life Sciences revenue growthKymera Therapeutics revenue growthCaris Life Sciences free cash flowKymera Therapeutics free cash flow
Caris Life Sciences & Kymera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.